EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, NBIX: Neurocrine Bioscienc

26 Nov 25 15:59
LAST:

151.6

CHANGE:
 8.05		OPEN:
144.2		HIGH:
153.5		ASK:
31.6		VOLUME:
933.9K
CHG(%):
5.61		PREV:
143.5		LOW:
144.2		BID:
36.5		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 Nov 25146.8153.5146.0151.61.73M
25 Nov 25141.7144.8140.7143.5631.7K
24 Nov 25142.0143.5139.3141.31.21M
21 Nov 25140.2144.8139.7141.8967.9K
20 Nov 25138.7141.1137.8139.0797.9K
19 Nov 25140.2140.2137.0138.11.09M
18 Nov 25143.0145.1138.4138.61.27M
17 Nov 25144.7145.9142.4143.6856.6K
14 Nov 25143.0146.4143.0144.9642.9K
13 Nov 25146.0148.8143.9144.2922.5K

PROFILE

Name:Neurocrine Bioscienc
About:Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Sector:Healthcare
Address:12780 El Camino Real, San Diego, CA, United States, 92130
Website:https://www.neurocrine.com
CUSIP:64125C109
CIK:0000914475
ISIN:US64125C1099
FIGI:BBG000GJS7C1
LEI:549300FECER0XBN49756

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:33.64 
Forward P/E:22.75 
PEG Ratio:0.48 
Price to Sales:5.25 
Price to Book:4.69 
Profit Margin:0.16 
Operating Margin:0.30 
Return on Assets:0.09 
Return on Equity:0.15 
EPS Ratio:3.38 
Revenue:2.683B 
EBITDA:493.6M 
Shares:99.18M 
Market Cap:15.038B 

TECHNICAL INDICATORS

MA5:143.435.7%
MA10:142.646.3%
MA20:144.904.6%
MA50:142.626.3%
MA100:138.659.4%
MA200:126.9319.4%
STO9:87.34 
STO14:82.24 
RSI14:45.09
WPR14:-5.52 
MTM14:-0.79
ROC14:-0.01 
ATR:5.04 
Week High:153.541.3%
Week Low:137.0210.7%
Month High:157.674.0%
Month Low:133.6119.4%
Year High:157.674.0%
Year Low:84.2380.0%
Volatility:29.87